Pharvaris N.V.

PHVS · Healthcare · Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases wit…

Pharvaris N.V. (PHVS), in the Healthcare sector, has 30 disclosed filings on Paydirt over the trailing twelve months from 11 corporate insiders: 0 purchases and 30 sales. Filers took a median of 3 days from execution to disclosure, and the most recent trade was executed Sep 17 and filed Sep 21. The most active filer was Peng Lu with 7 filings.

Add to watchlist

Filings, ttm

0 buys · 30 sells

Traders, ttm

11 insiders

Volume, ttmiDollar value disclosed in the window

$31.3M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 17

Filed yesterday

ADViAverage daily dollar volume

$16.8M

market data

Share price · 12M

$36.37 (+45.5%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $31.3M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Peng Lu President 7 filings AL

Anne Lesage Chief Early Development 5 filings RG

Robert Glassman Director 4 filings JS

Johannes Gerardus Christiaan Petrus Schikan Director 4 filings SA

Stefan Andreas Abele Chief Technical Ops Officer 2 filings EB

Elisabeth Bjork Director 2 filings WS

Wim Souverijns Chief Commercial Officer 2 filings BM

Berndt Modig Chief Executive Officer 1 filing

Recent filings

Peng LuSALE President $3.5M
100,000 sh × $35.00
Exec Sep 17
Filed Sep 21 · 4:20 PM ET Johannes Gerardus Christiaan Petrus SchikanSALE Director $7.0M
200,000 sh × $35.00
Exec Sep 17
Filed Sep 21 · 4:18 PM ET Elisabeth BjorkSALE Director $2.0M
52,500 sh × $37.89
Exec Sep 17
Filed Sep 21 · 3:20 PM ET Robert GlassmanSALE Director $559K
14,493 sh × $38.56
Exec Sep 17
Filed Sep 21 · 3:16 PM ET Anne LesageSALE Chief Early Development $765K
20,000 sh × $38.27
Exec Sep 17
Filed Sep 21 · 3:13 PM ET Stefan Andreas AbeleSALE Chief Technical Ops Officer $1.7M
45,000 sh × $38.14
Exec Sep 15
Filed Sep 17 · 1:22 PM ET Robert GlassmanSALE Director $332K
8,667 sh × $38.27
Exec Sep 15
Filed Sep 17 · 9:18 AM ET Wim SouverijnsSALE Chief Commercial Officer $1.0M
26,090 sh across 2 lots
Exec Sep 14
Filed Sep 16 · 2:07 PM ET Peng LuSALE President $602K
15,000 sh × $40.13
Exec Sep 11
Filed Sep 15 · 2:30 PM ET Anne LesageSALE Chief Early Development $1.1M
30,000 sh × $38.30
Exec Sep 10
Filed Sep 14 · 12:29 PM ET Robert GlassmanSALE Director $300K
8,000 sh × $37.55
Exec Sep 9
Filed Sep 11 · 12:25 PM ET Peng LuSALE President $610K
15,000 sh × $40.68
Exec Sep 8
Filed Sep 9 · 11:19 AM ET Johannes Gerardus Christiaan Petrus SchikanSALE Director $1.3M
37,600 sh across 2 lots
Exec Jun 29
Filed Jul 1 · 7:06 PM ET Anne LesageSALE Chief Early Development $2.6M
73,872 sh across 4 lots
Exec Jun 29
Filed Jul 1 · 7:02 PM ET Peng LuSALE Chief Medical Officer $1.0M
29,700 sh across 3 lots
Exec Jun 25
Filed Jun 29 · 5:30 PM ET David W. NassifSALE CFO / CLO $303K
10,000 sh × $30.31
Exec May 21
Filed May 26 · 5:30 PM ET Anna NijdamSALE Principal Accounting Officer $169K
5,501 sh × $30.74
Exec May 22
Filed May 26 · 5:30 PM ET Viviane MongesSALE Director $293K
9,667 sh × $30.29
Exec May 21
Filed May 26 · 5:30 PM ET Elisabeth BjorkSALE Director $293K
10,000 sh × $29.32
Exec May 20
Filed May 22 · 5:30 PM ET Wim SouverijnsSALE Chief Commercial Officer $299K
10,000 sh × $29.92
Exec May 15
Filed May 19 · 5:30 PM ET Stefan Andreas AbeleSALE Chief Technical Ops Officer $261K
8,748 sh × $29.82
Exec May 15
Filed May 19 · 5:30 PM ET Robert GlassmanSALE Director $298K
10,000 sh across 2 lots
Exec May 15
Filed May 19 · 5:30 PM ET Peng LuSALE Chief Medical Officer $423K
14,023 sh × $30.16
Exec May 1
Filed May 5 · 5:30 PM ET Peng LuSALE Chief Medical Officer $566K
18,733 sh across 2 lots
Exec Apr 29
Filed May 1 · 5:30 PM ET Anne LesageSALE Chief Early Development $1.5M
48,300 sh across 5 lots
Exec Apr 29
Filed May 1 · 5:30 PM ET